SlideShare uma empresa Scribd logo
1 de 25
Baixar para ler offline
Drug Dependence andDrug Dependence and
Drug AbuseDrug Abuse
TypeType ExamplesExamples Dependence liabilityDependence liability
Narcotic analgesicsNarcotic analgesics MorphineMorphine Very strongVery strong
   DiamorphineDiamorphine Very strongVery strong
General CNS depressantsGeneral CNS depressants EthanolEthanol StrongStrong
   BarbituratesBarbiturates StrongStrong
   MethaqualoneMethaqualone ModerateModerate
   GlutethimideGlutethimide ModerateModerate
   AnaestheticsAnaesthetics ModerateModerate
   SolventsSolvents StrongStrong
Anxiolytic drugsAnxiolytic drugs BenzodiazepinesBenzodiazepines ModerateModerate
Psychomotor stimulantsPsychomotor stimulants AmphetaminesAmphetamines StrongStrong
   CocaineCocaine Very strongVery strong
   CaffeineCaffeine WeakWeak
   NicotineNicotine Very strongVery strong
Psychotomimetic agentsPsychotomimetic agents LSDLSD Weak or absentWeak or absent
   MescalineMescaline Weak or absentWeak or absent
   PhencyclidinePhencyclidine ModerateModerate
   CannabisCannabis Weak or absentWeak or absent
Drug dependenceDrug dependence
 Dependence is defined as a compulsive cravingDependence is defined as a compulsive craving
that develops as a result of repeatedthat develops as a result of repeated
administration of the drug.administration of the drug.
 Dependence occurs with a wide range ofDependence occurs with a wide range of
psychotropic drugs, acting by many differentpsychotropic drugs, acting by many different
mechanisms.mechanisms.
 The common feature of dependence-producingThe common feature of dependence-producing
drugs is that they have a positive reinforcingdrugs is that they have a positive reinforcing
action ('reward') associated with activation ofaction ('reward') associated with activation of
the mesolimbic dopaminergic pathway.the mesolimbic dopaminergic pathway.
 dependence is often associated with (i)dependence is often associated with (i)
tolerance to the drug, which can arise by varioustolerance to the drug, which can arise by various
biochemical mechanisms; (ii) a physicalbiochemical mechanisms; (ii) a physical
abstinence syndrome, which varies in type andabstinence syndrome, which varies in type and
intensity for different classes of drug; (iii)intensity for different classes of drug; (iii)
psychological dependence (craving), which maypsychological dependence (craving), which may
be associated with the tolerance-producingbe associated with the tolerance-producing
biochemical changes.biochemical changes.
 Psychological dependence, which usuallyPsychological dependence, which usually
outlasts the physical withdrawal syndrome, is theoutlasts the physical withdrawal syndrome, is the
major factor leading to relapse among treatedmajor factor leading to relapse among treated
addicts.addicts.
 Though genetic factors contribute to drug-Though genetic factors contribute to drug-
seeking behaviour, no specific genes have yetseeking behaviour, no specific genes have yet
been identified.been identified.
Pharmacological approaches to treating drug dependencePharmacological approaches to treating drug dependence
MechanismMechanism ExamplesExamples
Substitution, to alleviateSubstitution, to alleviate
withdrawal symptomswithdrawal symptoms
Methadone, used short-term to blunt opiateMethadone, used short-term to blunt opiate
withdrawalwithdrawal
   Benzodiazepines, to blunt alcohol withdrawalBenzodiazepines, to blunt alcohol withdrawal
Long-term substitutionLong-term substitution Methadone substitution for opiate addictionMethadone substitution for opiate addiction
   Nicotine patches or chewing gumNicotine patches or chewing gum
Blocking responseBlocking response Naltrexone to block opiate effectsNaltrexone to block opiate effects
   Mecamylamine to block nicotine effectsMecamylamine to block nicotine effects
  
Immunisation against cocaine to produce circulatingImmunisation against cocaine to produce circulating
antibody (not yet proven)antibody (not yet proven)
Aversive therapiesAversive therapies Disulfiram to induce unpleasant response to ethanolDisulfiram to induce unpleasant response to ethanol
Modification of cravingModification of craving Bupropion (antidepressant)Bupropion (antidepressant)
  
Naltrexone (blocks opiate receptors-also of value inNaltrexone (blocks opiate receptors-also of value in
treating other addictions)treating other addictions)
   Clonidine (α-adrenoceptor agonist)Clonidine (α-adrenoceptor agonist)
   Acamprosate (NMDA-receptor antagonist)Acamprosate (NMDA-receptor antagonist)
Pharmacology of nicotinePharmacology of nicotine
 At a cellular level, nicotine acts on nicotinicAt a cellular level, nicotine acts on nicotinic
acetylcholine receptors, mainly of the α4β2 subtype,acetylcholine receptors, mainly of the α4β2 subtype,
to cause neuronal excitation. Its central effects areto cause neuronal excitation. Its central effects are
blocked by receptor antagonists such asblocked by receptor antagonists such as
mecamylamine.mecamylamine.
 At the behavioural level, nicotine produces a mixtureAt the behavioural level, nicotine produces a mixture
of inhibitory and excitatory effects.of inhibitory and excitatory effects.
 Nicotine shows reinforcing properties, associated withNicotine shows reinforcing properties, associated with
increased activity in the mesolimbic dopaminergicincreased activity in the mesolimbic dopaminergic
pathway, and self-administration can be elicited inpathway, and self-administration can be elicited in
animal studies.animal studies.
Pharmacology of nicotinePharmacology of nicotine
Electroencephalography changes show anElectroencephalography changes show an
arousal response, and subjects reportarousal response, and subjects report
increased alertness, accompanied by aincreased alertness, accompanied by a
reduction of anxiety and tension.reduction of anxiety and tension.
Peripheral effects of nicotine result mainly fromPeripheral effects of nicotine result mainly from
ganglionic stimulation: tachycardia, increasedganglionic stimulation: tachycardia, increased
blood pressure and increase gastrointestinalblood pressure and increase gastrointestinal
motility. Tolerance develops rapidly to thesemotility. Tolerance develops rapidly to these
effects.effects.
Nicotine is metabolised, mainly in the liver,Nicotine is metabolised, mainly in the liver,
within 1-2 hours. Its inactive metabolite,within 1-2 hours. Its inactive metabolite,
cotinine, has a long plasma half-life andcotinine, has a long plasma half-life and
can be used as a measure of smokingcan be used as a measure of smoking
habits.habits.
Nicotine replacement therapy (chewingNicotine replacement therapy (chewing
gum or skin patch preparations) improvesgum or skin patch preparations) improves
the chances of giving up smoking, but onlythe chances of giving up smoking, but only
when combined with active counselling.when combined with active counselling.
NicotineNicotine
NicotineNicotine
Effects of ethanolEffects of ethanol
Ethanol acts as a general CNSEthanol acts as a general CNS
depressant, similar to volatile anaestheticdepressant, similar to volatile anaesthetic
agents, producing the familiar effects ofagents, producing the familiar effects of
acute intoxication.acute intoxication.
Several cellular mechanisms areSeveral cellular mechanisms are
postulated: inhibition of calcium channelpostulated: inhibition of calcium channel
opening, enhancement of GABA actionopening, enhancement of GABA action
and inhibitory action at NMDA-typeand inhibitory action at NMDA-type
glutamate receptors.glutamate receptors.
Effective plasma concentrations:Effective plasma concentrations:
threshold effects: about 40 mg/100 mlthreshold effects: about 40 mg/100 ml
(5 mmol/l)(5 mmol/l)
severe intoxication: about 150 mg/100severe intoxication: about 150 mg/100
mlml
death from respiratory failure: about 500death from respiratory failure: about 500
mg/100 ml.mg/100 ml.
Main peripheral effects are self-limitingMain peripheral effects are self-limiting
diuresis (reduced antidiuretic hormonediuresis (reduced antidiuretic hormone
secretion), cutaneous vasodilatation andsecretion), cutaneous vasodilatation and
delayed labor (reduced oxytocindelayed labor (reduced oxytocin
secretion).secretion).
Neurological degeneration occurs inNeurological degeneration occurs in
heavy drinkers, causing dementia andheavy drinkers, causing dementia and
peripheral neuropathies.peripheral neuropathies.
Effects of ethanolEffects of ethanol
 Long-term ethanol consumption causes liver disease,Long-term ethanol consumption causes liver disease,
progressing to cirrhosis and liver failure.progressing to cirrhosis and liver failure.
 Moderate ethanol consumption has a protective effectModerate ethanol consumption has a protective effect
against ischemic heart disease.against ischemic heart disease.
 Excessive consumption in pregnancy causes impairedExcessive consumption in pregnancy causes impaired
fetal development, associated with small size, abnormalfetal development, associated with small size, abnormal
facial development and other physical abnormalities, andfacial development and other physical abnormalities, and
mental retardation.mental retardation.
 Tolerance, physical dependence and psychologicalTolerance, physical dependence and psychological
dependence all occur with ethanol.dependence all occur with ethanol.
 Drugs used to treat alcohol dependence includeDrugs used to treat alcohol dependence include
disulfiram (aldehyde dehydrogenase inhibitor),disulfiram (aldehyde dehydrogenase inhibitor),
naltrexone (opiate antagonist) and acamprosate (NMDA-naltrexone (opiate antagonist) and acamprosate (NMDA-
receptor antagonist).receptor antagonist).
Metabolism of ethanol.
Fetal Alcohol SyndromeFetal Alcohol Syndrome
Fetal Alcohol SyndromeFetal Alcohol Syndrome
CannabisCannabis
 Main active constituent is Δ9-tetrahydro cannabinol (THC),Main active constituent is Δ9-tetrahydro cannabinol (THC),
though pharmacologically active metabolites may bethough pharmacologically active metabolites may be
important.important.
 Actions on CNS include both depressant andActions on CNS include both depressant and
psychotomimetic effects.psychotomimetic effects.
 Subjectively, subjects experience euphoria and a feeling ofSubjectively, subjects experience euphoria and a feeling of
relaxation, with sharpened sensory awareness.relaxation, with sharpened sensory awareness.
 THC also shows analgesic and antiemetic activity,THC also shows analgesic and antiemetic activity,
 Peripheral actions include vasodilatation, reduction ofPeripheral actions include vasodilatation, reduction of
intraocular pressure and bronchodilatation.intraocular pressure and bronchodilatation.
 Cannabinoid receptors belong to the G-protein-coupledCannabinoid receptors belong to the G-protein-coupled
receptor family, linked to inhibition of adenylate cyclase andreceptor family, linked to inhibition of adenylate cyclase and
effects on calcium and potassium channel function, causingeffects on calcium and potassium channel function, causing
inhibition of synaptic transmission.inhibition of synaptic transmission.
CannabisCannabis
 Anandamide, an arachidonic acid derivative, is anAnandamide, an arachidonic acid derivative, is an
endogenous ligand for the CNS cannabinoid receptor; itsendogenous ligand for the CNS cannabinoid receptor; its
function has not yet been ascertained.function has not yet been ascertained.
 Cannabinoids are less liable than opiates, nicotine orCannabinoids are less liable than opiates, nicotine or
alcohol to cause dependence but may have long-termalcohol to cause dependence but may have long-term
psychological effects.psychological effects.
 Nabilone, a THC analogue, has been developed for itsNabilone, a THC analogue, has been developed for its
antiemetic property.antiemetic property.
 Though cannabinoids are not available for clinical use,Though cannabinoids are not available for clinical use,
trials are in progress for symptomatic treatment oftrials are in progress for symptomatic treatment of
multiple sclerosis and AIDS.multiple sclerosis and AIDS.
MarijuanaMarijuana
MarijuanaMarijuana
HallucinogensHallucinogens
LSDLSD
CocaineCocaine
CocaineCocaine
Drug dependence and drug abuse

Mais conteúdo relacionado

Mais procurados (20)

Antidepressants
AntidepressantsAntidepressants
Antidepressants
 
Sedatives and hypnotics
Sedatives and hypnotics Sedatives and hypnotics
Sedatives and hypnotics
 
Drug Abuse, Dependence & Addiction
Drug Abuse, Dependence & AddictionDrug Abuse, Dependence & Addiction
Drug Abuse, Dependence & Addiction
 
drugs used in myasthenia gravis
drugs used in myasthenia gravisdrugs used in myasthenia gravis
drugs used in myasthenia gravis
 
Dependence
DependenceDependence
Dependence
 
Introduction to Neuropharmacology
Introduction to Neuropharmacology Introduction to Neuropharmacology
Introduction to Neuropharmacology
 
Chapter 12 Hallucinogens
Chapter 12  HallucinogensChapter 12  Hallucinogens
Chapter 12 Hallucinogens
 
Anti depressant and its classifications
Anti depressant and its classificationsAnti depressant and its classifications
Anti depressant and its classifications
 
Sedative Hypnotic
Sedative HypnoticSedative Hypnotic
Sedative Hypnotic
 
Schizophrenia and Antipsychotic Drugs
Schizophrenia and Antipsychotic DrugsSchizophrenia and Antipsychotic Drugs
Schizophrenia and Antipsychotic Drugs
 
Pharmacology - Parkinsonism
Pharmacology - ParkinsonismPharmacology - Parkinsonism
Pharmacology - Parkinsonism
 
ANTIDEPRESSANTS
ANTIDEPRESSANTSANTIDEPRESSANTS
ANTIDEPRESSANTS
 
Antianxiety drugs
Antianxiety drugsAntianxiety drugs
Antianxiety drugs
 
Narcotics and non narcotics analgesics
Narcotics and non narcotics analgesicsNarcotics and non narcotics analgesics
Narcotics and non narcotics analgesics
 
Drugs of Abuse: Hallucinogens
Drugs of Abuse: HallucinogensDrugs of Abuse: Hallucinogens
Drugs of Abuse: Hallucinogens
 
3.4 alcohol & disulfiram
3.4 alcohol & disulfiram3.4 alcohol & disulfiram
3.4 alcohol & disulfiram
 
Antiepileptics
AntiepilepticsAntiepileptics
Antiepileptics
 
Cns depressants
Cns depressantsCns depressants
Cns depressants
 
Pathophysiology of depression
Pathophysiology of depressionPathophysiology of depression
Pathophysiology of depression
 
Antipsychotics
AntipsychoticsAntipsychotics
Antipsychotics
 

Destaque

Medicine manufacturing units in hospitals
Medicine manufacturing units in hospitalsMedicine manufacturing units in hospitals
Medicine manufacturing units in hospitalsAhmed Fathy
 
Adverse drug reactions
Adverse drug  reactionsAdverse drug  reactions
Adverse drug reactionssuniu
 
Class NEWER ROUTES OF DRUG ADMINISTRATION
Class NEWER ROUTES OF DRUG ADMINISTRATIONClass NEWER ROUTES OF DRUG ADMINISTRATION
Class NEWER ROUTES OF DRUG ADMINISTRATIONRaghu Prasada
 
Factors bioavailability by d hi man saab
Factors bioavailability by d hi man saabFactors bioavailability by d hi man saab
Factors bioavailability by d hi man saabMANISH KUMAR
 
Adverse Drug Reactions - Identifying, Causality & Reporting
Adverse Drug Reactions - Identifying, Causality & ReportingAdverse Drug Reactions - Identifying, Causality & Reporting
Adverse Drug Reactions - Identifying, Causality & ReportingRuella D'Costa Fernandes
 
Adverse drug reactions
Adverse drug reactionsAdverse drug reactions
Adverse drug reactionsDr.Vijay Talla
 
Drug Dependence & Abuse - Presentation by Akshay Anand
Drug Dependence & Abuse - Presentation by Akshay AnandDrug Dependence & Abuse - Presentation by Akshay Anand
Drug Dependence & Abuse - Presentation by Akshay AnandAkshay Anand
 

Destaque (14)

Medicine manufacturing units in hospitals
Medicine manufacturing units in hospitalsMedicine manufacturing units in hospitals
Medicine manufacturing units in hospitals
 
Adverse drug reactions
Adverse drug  reactionsAdverse drug  reactions
Adverse drug reactions
 
Surgical aids
Surgical aids Surgical aids
Surgical aids
 
Class NEWER ROUTES OF DRUG ADMINISTRATION
Class NEWER ROUTES OF DRUG ADMINISTRATIONClass NEWER ROUTES OF DRUG ADMINISTRATION
Class NEWER ROUTES OF DRUG ADMINISTRATION
 
Lectures 11 Bioavailability
Lectures 11 BioavailabilityLectures 11 Bioavailability
Lectures 11 Bioavailability
 
Factors bioavailability by d hi man saab
Factors bioavailability by d hi man saabFactors bioavailability by d hi man saab
Factors bioavailability by d hi man saab
 
Adverse Drug Reactions
Adverse Drug ReactionsAdverse Drug Reactions
Adverse Drug Reactions
 
Adverse drug reactions ppt
Adverse drug reactions pptAdverse drug reactions ppt
Adverse drug reactions ppt
 
Adverse Drug Reactions - Identifying, Causality & Reporting
Adverse Drug Reactions - Identifying, Causality & ReportingAdverse Drug Reactions - Identifying, Causality & Reporting
Adverse Drug Reactions - Identifying, Causality & Reporting
 
Adverse drug reactions
Adverse drug reactionsAdverse drug reactions
Adverse drug reactions
 
Drug Dependence & Abuse - Presentation by Akshay Anand
Drug Dependence & Abuse - Presentation by Akshay AnandDrug Dependence & Abuse - Presentation by Akshay Anand
Drug Dependence & Abuse - Presentation by Akshay Anand
 
Adverse drug reactions
Adverse drug reactionsAdverse drug reactions
Adverse drug reactions
 
Adverse drug reactions
Adverse drug reactionsAdverse drug reactions
Adverse drug reactions
 
Bioavailability Studies
Bioavailability StudiesBioavailability Studies
Bioavailability Studies
 

Semelhante a Drug dependence and drug abuse

Drug addiction neurobiology
Drug addiction neurobiologyDrug addiction neurobiology
Drug addiction neurobiologySyed Shams
 
Psychiatric drugs of abuse
Psychiatric drugs of abusePsychiatric drugs of abuse
Psychiatric drugs of abusejohn522129
 
NEUROOO.ppt
NEUROOO.pptNEUROOO.ppt
NEUROOO.pptRumi80
 
Disorders of the reward system
Disorders of the reward systemDisorders of the reward system
Disorders of the reward systemAdonis Sfera, MD
 
Effective treatment for drug addiction in Mindheal Homeopathy clinic ,Chembur...
Effective treatment for drug addiction in Mindheal Homeopathy clinic ,Chembur...Effective treatment for drug addiction in Mindheal Homeopathy clinic ,Chembur...
Effective treatment for drug addiction in Mindheal Homeopathy clinic ,Chembur...Shewta shetty
 
Antidepressants mood_stabilizers
Antidepressants  mood_stabilizersAntidepressants  mood_stabilizers
Antidepressants mood_stabilizersUniversity of Miami
 
Homeopathic Doctor - Dr. Anita Salunke homeopathic clinic for Drug Addiction ...
Homeopathic Doctor - Dr. Anita Salunke homeopathic clinic for Drug Addiction ...Homeopathic Doctor - Dr. Anita Salunke homeopathic clinic for Drug Addiction ...
Homeopathic Doctor - Dr. Anita Salunke homeopathic clinic for Drug Addiction ...Shewta shetty
 
CNS PHARMACOLOGY.pptx
CNS PHARMACOLOGY.pptxCNS PHARMACOLOGY.pptx
CNS PHARMACOLOGY.pptxLijFire
 
Management of movement disorders
Management of movement disordersManagement of movement disorders
Management of movement disordersRavi Soni
 
Parkinson's disease pharmacology
Parkinson's disease pharmacologyParkinson's disease pharmacology
Parkinson's disease pharmacologyZuaib Aktar
 
Drugs used in Parkinsonism
Drugs used in Parkinsonism Drugs used in Parkinsonism
Drugs used in Parkinsonism Talha Yousuf
 

Semelhante a Drug dependence and drug abuse (20)

Neurobiology of addiction padova
Neurobiology of addiction padovaNeurobiology of addiction padova
Neurobiology of addiction padova
 
Drug addiction neurobiology
Drug addiction neurobiologyDrug addiction neurobiology
Drug addiction neurobiology
 
Psychiatric drugs of abuse
Psychiatric drugs of abusePsychiatric drugs of abuse
Psychiatric drugs of abuse
 
NEUROOO.ppt
NEUROOO.pptNEUROOO.ppt
NEUROOO.ppt
 
Antidepressant
AntidepressantAntidepressant
Antidepressant
 
Stimulants
Stimulants Stimulants
Stimulants
 
Disorders of the reward system
Disorders of the reward systemDisorders of the reward system
Disorders of the reward system
 
Effective treatment for drug addiction in Mindheal Homeopathy clinic ,Chembur...
Effective treatment for drug addiction in Mindheal Homeopathy clinic ,Chembur...Effective treatment for drug addiction in Mindheal Homeopathy clinic ,Chembur...
Effective treatment for drug addiction in Mindheal Homeopathy clinic ,Chembur...
 
Antidepressants mood_stabilizers
Antidepressants  mood_stabilizersAntidepressants  mood_stabilizers
Antidepressants mood_stabilizers
 
Tobacco Addiction
Tobacco AddictionTobacco Addiction
Tobacco Addiction
 
Homeopathic Doctor - Dr. Anita Salunke homeopathic clinic for Drug Addiction ...
Homeopathic Doctor - Dr. Anita Salunke homeopathic clinic for Drug Addiction ...Homeopathic Doctor - Dr. Anita Salunke homeopathic clinic for Drug Addiction ...
Homeopathic Doctor - Dr. Anita Salunke homeopathic clinic for Drug Addiction ...
 
Ads treatment
Ads treatmentAds treatment
Ads treatment
 
Parkinson s disease
Parkinson s diseaseParkinson s disease
Parkinson s disease
 
CNS PHARMACOLOGY.pptx
CNS PHARMACOLOGY.pptxCNS PHARMACOLOGY.pptx
CNS PHARMACOLOGY.pptx
 
3 general anethesia
3 general anethesia3 general anethesia
3 general anethesia
 
Management of movement disorders
Management of movement disordersManagement of movement disorders
Management of movement disorders
 
Tox and seizures
Tox and seizuresTox and seizures
Tox and seizures
 
Antiepiletics
AntiepileticsAntiepiletics
Antiepiletics
 
Parkinson's disease pharmacology
Parkinson's disease pharmacologyParkinson's disease pharmacology
Parkinson's disease pharmacology
 
Drugs used in Parkinsonism
Drugs used in Parkinsonism Drugs used in Parkinsonism
Drugs used in Parkinsonism
 

Mais de Fred Ecaldre

Mais de Fred Ecaldre (19)

Psr
PsrPsr
Psr
 
Gastrointestinal drugs pharma
Gastrointestinal drugs pharmaGastrointestinal drugs pharma
Gastrointestinal drugs pharma
 
Molecular neuropharma
Molecular neuropharmaMolecular neuropharma
Molecular neuropharma
 
Seminar
SeminarSeminar
Seminar
 
Cvs drugs new
Cvs drugs   newCvs drugs   new
Cvs drugs new
 
Neurodegenerative disorders
Neurodegenerative disordersNeurodegenerative disorders
Neurodegenerative disorders
 
Nursing ppt
Nursing pptNursing ppt
Nursing ppt
 
Mcn2
Mcn2Mcn2
Mcn2
 
Anxiolytic and hypnotic drugs
Anxiolytic and hypnotic drugsAnxiolytic and hypnotic drugs
Anxiolytic and hypnotic drugs
 
Arthritis
ArthritisArthritis
Arthritis
 
Pharmacology powerpoint git drugs
Pharmacology powerpoint  git drugsPharmacology powerpoint  git drugs
Pharmacology powerpoint git drugs
 
Antiepileptic drugs
Antiepileptic drugsAntiepileptic drugs
Antiepileptic drugs
 
Ho6
Ho6Ho6
Ho6
 
Endocrine drugs
Endocrine drugsEndocrine drugs
Endocrine drugs
 
General anaesthetic agents
General anaesthetic agentsGeneral anaesthetic agents
General anaesthetic agents
 
Antipsychotic drugs
Antipsychotic drugsAntipsychotic drugs
Antipsychotic drugs
 
Anxiolytic new
Anxiolytic newAnxiolytic new
Anxiolytic new
 
Antidepressants
AntidepressantsAntidepressants
Antidepressants
 
Analgesic drugs
Analgesic drugsAnalgesic drugs
Analgesic drugs
 

Último

"Radical excision of DIE in subferile women with deep infiltrating endometrio...
"Radical excision of DIE in subferile women with deep infiltrating endometrio..."Radical excision of DIE in subferile women with deep infiltrating endometrio...
"Radical excision of DIE in subferile women with deep infiltrating endometrio...Sujoy Dasgupta
 
Male Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondMale Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondSujoy Dasgupta
 
MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.whalesdesign
 
AI in Action: Elevating Patient Insights
AI in Action: Elevating Patient InsightsAI in Action: Elevating Patient Insights
AI in Action: Elevating Patient InsightsEmily Kunka, MS, CCRP
 
Male Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy DasguptaMale Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy DasguptaSujoy Dasgupta
 
Transport across cell membrane (passive, active, vesicular)
Transport across cell membrane (passive, active, vesicular)Transport across cell membrane (passive, active, vesicular)
Transport across cell membrane (passive, active, vesicular)MedicoseAcademics
 
BENIGN BREAST DISEASE
BENIGN BREAST DISEASE BENIGN BREAST DISEASE
BENIGN BREAST DISEASE Mamatha Lakka
 
A presentation on Thermal gravimetry analysis (TGA)
A presentation on Thermal gravimetry analysis (TGA)A presentation on Thermal gravimetry analysis (TGA)
A presentation on Thermal gravimetry analysis (TGA)1922Jaygohel
 
Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.kishan singh tomar
 
Using Data Visualization in Public Health Communications
Using Data Visualization in Public Health CommunicationsUsing Data Visualization in Public Health Communications
Using Data Visualization in Public Health Communicationskatiequigley33
 
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfSGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfHongBiThi1
 
Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Vaikunthan Rajaratnam
 
ayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptPradnya Wadekar
 
Employability skills, work experience presentation
Employability skills, work experience presentationEmployability skills, work experience presentation
Employability skills, work experience presentationmarwaahmad357
 
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D.  Bawankar.pptPharmacokinetic Models by Dr. Ram D.  Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D. Bawankar.pptRamDBawankar1
 
Cure of patients which terminally ill.pdf
Cure of patients which terminally ill.pdfCure of patients which terminally ill.pdf
Cure of patients which terminally ill.pdfrg0000009
 
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfPAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfDolisha Warbi
 
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdfSGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdfHongBiThi1
 

Último (20)

"Radical excision of DIE in subferile women with deep infiltrating endometrio...
"Radical excision of DIE in subferile women with deep infiltrating endometrio..."Radical excision of DIE in subferile women with deep infiltrating endometrio...
"Radical excision of DIE in subferile women with deep infiltrating endometrio...
 
Male Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondMale Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and Beyond
 
MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.
 
AI in Action: Elevating Patient Insights
AI in Action: Elevating Patient InsightsAI in Action: Elevating Patient Insights
AI in Action: Elevating Patient Insights
 
Male Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy DasguptaMale Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy Dasgupta
 
Transport across cell membrane (passive, active, vesicular)
Transport across cell membrane (passive, active, vesicular)Transport across cell membrane (passive, active, vesicular)
Transport across cell membrane (passive, active, vesicular)
 
BENIGN BREAST DISEASE
BENIGN BREAST DISEASE BENIGN BREAST DISEASE
BENIGN BREAST DISEASE
 
A presentation on Thermal gravimetry analysis (TGA)
A presentation on Thermal gravimetry analysis (TGA)A presentation on Thermal gravimetry analysis (TGA)
A presentation on Thermal gravimetry analysis (TGA)
 
Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.
 
Using Data Visualization in Public Health Communications
Using Data Visualization in Public Health CommunicationsUsing Data Visualization in Public Health Communications
Using Data Visualization in Public Health Communications
 
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfSGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
 
Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.
 
ayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologyppt
 
Employability skills, work experience presentation
Employability skills, work experience presentationEmployability skills, work experience presentation
Employability skills, work experience presentation
 
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D.  Bawankar.pptPharmacokinetic Models by Dr. Ram D.  Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
 
Cure of patients which terminally ill.pdf
Cure of patients which terminally ill.pdfCure of patients which terminally ill.pdf
Cure of patients which terminally ill.pdf
 
American College of physicians ACP high value care recommendations in rheumat...
American College of physicians ACP high value care recommendations in rheumat...American College of physicians ACP high value care recommendations in rheumat...
American College of physicians ACP high value care recommendations in rheumat...
 
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfPAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
 
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
 
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdfSGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdf
 

Drug dependence and drug abuse

  • 1. Drug Dependence andDrug Dependence and Drug AbuseDrug Abuse
  • 2. TypeType ExamplesExamples Dependence liabilityDependence liability Narcotic analgesicsNarcotic analgesics MorphineMorphine Very strongVery strong    DiamorphineDiamorphine Very strongVery strong General CNS depressantsGeneral CNS depressants EthanolEthanol StrongStrong    BarbituratesBarbiturates StrongStrong    MethaqualoneMethaqualone ModerateModerate    GlutethimideGlutethimide ModerateModerate    AnaestheticsAnaesthetics ModerateModerate    SolventsSolvents StrongStrong Anxiolytic drugsAnxiolytic drugs BenzodiazepinesBenzodiazepines ModerateModerate Psychomotor stimulantsPsychomotor stimulants AmphetaminesAmphetamines StrongStrong    CocaineCocaine Very strongVery strong    CaffeineCaffeine WeakWeak    NicotineNicotine Very strongVery strong Psychotomimetic agentsPsychotomimetic agents LSDLSD Weak or absentWeak or absent    MescalineMescaline Weak or absentWeak or absent    PhencyclidinePhencyclidine ModerateModerate    CannabisCannabis Weak or absentWeak or absent
  • 3. Drug dependenceDrug dependence  Dependence is defined as a compulsive cravingDependence is defined as a compulsive craving that develops as a result of repeatedthat develops as a result of repeated administration of the drug.administration of the drug.  Dependence occurs with a wide range ofDependence occurs with a wide range of psychotropic drugs, acting by many differentpsychotropic drugs, acting by many different mechanisms.mechanisms.  The common feature of dependence-producingThe common feature of dependence-producing drugs is that they have a positive reinforcingdrugs is that they have a positive reinforcing action ('reward') associated with activation ofaction ('reward') associated with activation of the mesolimbic dopaminergic pathway.the mesolimbic dopaminergic pathway.
  • 4.  dependence is often associated with (i)dependence is often associated with (i) tolerance to the drug, which can arise by varioustolerance to the drug, which can arise by various biochemical mechanisms; (ii) a physicalbiochemical mechanisms; (ii) a physical abstinence syndrome, which varies in type andabstinence syndrome, which varies in type and intensity for different classes of drug; (iii)intensity for different classes of drug; (iii) psychological dependence (craving), which maypsychological dependence (craving), which may be associated with the tolerance-producingbe associated with the tolerance-producing biochemical changes.biochemical changes.  Psychological dependence, which usuallyPsychological dependence, which usually outlasts the physical withdrawal syndrome, is theoutlasts the physical withdrawal syndrome, is the major factor leading to relapse among treatedmajor factor leading to relapse among treated addicts.addicts.  Though genetic factors contribute to drug-Though genetic factors contribute to drug- seeking behaviour, no specific genes have yetseeking behaviour, no specific genes have yet been identified.been identified.
  • 5. Pharmacological approaches to treating drug dependencePharmacological approaches to treating drug dependence MechanismMechanism ExamplesExamples Substitution, to alleviateSubstitution, to alleviate withdrawal symptomswithdrawal symptoms Methadone, used short-term to blunt opiateMethadone, used short-term to blunt opiate withdrawalwithdrawal    Benzodiazepines, to blunt alcohol withdrawalBenzodiazepines, to blunt alcohol withdrawal Long-term substitutionLong-term substitution Methadone substitution for opiate addictionMethadone substitution for opiate addiction    Nicotine patches or chewing gumNicotine patches or chewing gum Blocking responseBlocking response Naltrexone to block opiate effectsNaltrexone to block opiate effects    Mecamylamine to block nicotine effectsMecamylamine to block nicotine effects    Immunisation against cocaine to produce circulatingImmunisation against cocaine to produce circulating antibody (not yet proven)antibody (not yet proven) Aversive therapiesAversive therapies Disulfiram to induce unpleasant response to ethanolDisulfiram to induce unpleasant response to ethanol Modification of cravingModification of craving Bupropion (antidepressant)Bupropion (antidepressant)    Naltrexone (blocks opiate receptors-also of value inNaltrexone (blocks opiate receptors-also of value in treating other addictions)treating other addictions)    Clonidine (α-adrenoceptor agonist)Clonidine (α-adrenoceptor agonist)    Acamprosate (NMDA-receptor antagonist)Acamprosate (NMDA-receptor antagonist)
  • 6. Pharmacology of nicotinePharmacology of nicotine  At a cellular level, nicotine acts on nicotinicAt a cellular level, nicotine acts on nicotinic acetylcholine receptors, mainly of the α4β2 subtype,acetylcholine receptors, mainly of the α4β2 subtype, to cause neuronal excitation. Its central effects areto cause neuronal excitation. Its central effects are blocked by receptor antagonists such asblocked by receptor antagonists such as mecamylamine.mecamylamine.  At the behavioural level, nicotine produces a mixtureAt the behavioural level, nicotine produces a mixture of inhibitory and excitatory effects.of inhibitory and excitatory effects.  Nicotine shows reinforcing properties, associated withNicotine shows reinforcing properties, associated with increased activity in the mesolimbic dopaminergicincreased activity in the mesolimbic dopaminergic pathway, and self-administration can be elicited inpathway, and self-administration can be elicited in animal studies.animal studies.
  • 7. Pharmacology of nicotinePharmacology of nicotine Electroencephalography changes show anElectroencephalography changes show an arousal response, and subjects reportarousal response, and subjects report increased alertness, accompanied by aincreased alertness, accompanied by a reduction of anxiety and tension.reduction of anxiety and tension. Peripheral effects of nicotine result mainly fromPeripheral effects of nicotine result mainly from ganglionic stimulation: tachycardia, increasedganglionic stimulation: tachycardia, increased blood pressure and increase gastrointestinalblood pressure and increase gastrointestinal motility. Tolerance develops rapidly to thesemotility. Tolerance develops rapidly to these effects.effects.
  • 8. Nicotine is metabolised, mainly in the liver,Nicotine is metabolised, mainly in the liver, within 1-2 hours. Its inactive metabolite,within 1-2 hours. Its inactive metabolite, cotinine, has a long plasma half-life andcotinine, has a long plasma half-life and can be used as a measure of smokingcan be used as a measure of smoking habits.habits. Nicotine replacement therapy (chewingNicotine replacement therapy (chewing gum or skin patch preparations) improvesgum or skin patch preparations) improves the chances of giving up smoking, but onlythe chances of giving up smoking, but only when combined with active counselling.when combined with active counselling.
  • 11. Effects of ethanolEffects of ethanol Ethanol acts as a general CNSEthanol acts as a general CNS depressant, similar to volatile anaestheticdepressant, similar to volatile anaesthetic agents, producing the familiar effects ofagents, producing the familiar effects of acute intoxication.acute intoxication. Several cellular mechanisms areSeveral cellular mechanisms are postulated: inhibition of calcium channelpostulated: inhibition of calcium channel opening, enhancement of GABA actionopening, enhancement of GABA action and inhibitory action at NMDA-typeand inhibitory action at NMDA-type glutamate receptors.glutamate receptors.
  • 12. Effective plasma concentrations:Effective plasma concentrations: threshold effects: about 40 mg/100 mlthreshold effects: about 40 mg/100 ml (5 mmol/l)(5 mmol/l) severe intoxication: about 150 mg/100severe intoxication: about 150 mg/100 mlml death from respiratory failure: about 500death from respiratory failure: about 500 mg/100 ml.mg/100 ml. Main peripheral effects are self-limitingMain peripheral effects are self-limiting diuresis (reduced antidiuretic hormonediuresis (reduced antidiuretic hormone secretion), cutaneous vasodilatation andsecretion), cutaneous vasodilatation and delayed labor (reduced oxytocindelayed labor (reduced oxytocin secretion).secretion). Neurological degeneration occurs inNeurological degeneration occurs in heavy drinkers, causing dementia andheavy drinkers, causing dementia and peripheral neuropathies.peripheral neuropathies.
  • 13. Effects of ethanolEffects of ethanol  Long-term ethanol consumption causes liver disease,Long-term ethanol consumption causes liver disease, progressing to cirrhosis and liver failure.progressing to cirrhosis and liver failure.  Moderate ethanol consumption has a protective effectModerate ethanol consumption has a protective effect against ischemic heart disease.against ischemic heart disease.  Excessive consumption in pregnancy causes impairedExcessive consumption in pregnancy causes impaired fetal development, associated with small size, abnormalfetal development, associated with small size, abnormal facial development and other physical abnormalities, andfacial development and other physical abnormalities, and mental retardation.mental retardation.  Tolerance, physical dependence and psychologicalTolerance, physical dependence and psychological dependence all occur with ethanol.dependence all occur with ethanol.  Drugs used to treat alcohol dependence includeDrugs used to treat alcohol dependence include disulfiram (aldehyde dehydrogenase inhibitor),disulfiram (aldehyde dehydrogenase inhibitor), naltrexone (opiate antagonist) and acamprosate (NMDA-naltrexone (opiate antagonist) and acamprosate (NMDA- receptor antagonist).receptor antagonist).
  • 15. Fetal Alcohol SyndromeFetal Alcohol Syndrome
  • 16. Fetal Alcohol SyndromeFetal Alcohol Syndrome
  • 17. CannabisCannabis  Main active constituent is Δ9-tetrahydro cannabinol (THC),Main active constituent is Δ9-tetrahydro cannabinol (THC), though pharmacologically active metabolites may bethough pharmacologically active metabolites may be important.important.  Actions on CNS include both depressant andActions on CNS include both depressant and psychotomimetic effects.psychotomimetic effects.  Subjectively, subjects experience euphoria and a feeling ofSubjectively, subjects experience euphoria and a feeling of relaxation, with sharpened sensory awareness.relaxation, with sharpened sensory awareness.  THC also shows analgesic and antiemetic activity,THC also shows analgesic and antiemetic activity,  Peripheral actions include vasodilatation, reduction ofPeripheral actions include vasodilatation, reduction of intraocular pressure and bronchodilatation.intraocular pressure and bronchodilatation.  Cannabinoid receptors belong to the G-protein-coupledCannabinoid receptors belong to the G-protein-coupled receptor family, linked to inhibition of adenylate cyclase andreceptor family, linked to inhibition of adenylate cyclase and effects on calcium and potassium channel function, causingeffects on calcium and potassium channel function, causing inhibition of synaptic transmission.inhibition of synaptic transmission.
  • 18. CannabisCannabis  Anandamide, an arachidonic acid derivative, is anAnandamide, an arachidonic acid derivative, is an endogenous ligand for the CNS cannabinoid receptor; itsendogenous ligand for the CNS cannabinoid receptor; its function has not yet been ascertained.function has not yet been ascertained.  Cannabinoids are less liable than opiates, nicotine orCannabinoids are less liable than opiates, nicotine or alcohol to cause dependence but may have long-termalcohol to cause dependence but may have long-term psychological effects.psychological effects.  Nabilone, a THC analogue, has been developed for itsNabilone, a THC analogue, has been developed for its antiemetic property.antiemetic property.  Though cannabinoids are not available for clinical use,Though cannabinoids are not available for clinical use, trials are in progress for symptomatic treatment oftrials are in progress for symptomatic treatment of multiple sclerosis and AIDS.multiple sclerosis and AIDS.